Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signalling pathways in a nutshell: from pathogenesis to therapeutical implications in prostate cancer. | Ann Med | 2025 | 40372974 | PubTator, text mining | PubMed |
| INHBA+ macrophages and Pro-inflammatory CAFs are associated with distinctive immunosuppressive tumor microenvironment in submucous Fibrosis-Derived oral squamous cell carcinoma. | BMC Cancer | 2025 | 40355814 | PubTator, text mining | PubMed |
| Emerging Therapeutic Approaches for Anemia in Myelofibrosis. | Curr Hematol Malig Rep | 2025 | 40317385 | PubTator, text mining | PubMed |
| Advancements in mechanisms and drug treatments for fibrodysplasia ossificans progressiva. | J Zhejiang Univ Sci B | 2025 | 40274382 | PubTator, text mining | PubMed |
| An oncohistone-driven H3.3K27M/CREB5/ID1 axis maintains the stemness and malignancy of diffuse intrinsic pontine glioma. | Nat Commun | 2025 | 40246858 | PubTator, text mining | PubMed |
| Modernizing CTSA hub evaluation: an integrated system for performance monitoring and translational science impact assessment. | Front Res Metr Anal | 2025 | 40231104 | PubTator, text mining | PubMed |
| Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer. | Cancers (Basel) | 2025 | 40227607 | PubTator, text mining | PubMed |
| FOP: From Biomolecules to Hope. | Biomolecules | 2025 | 40149864 | PubTator, text mining | PubMed |
| Expression and distribution of activin-follistatin-inhibin axis in the urinary bladder. | Front Mol Biosci | 2025 | 40144023 | PubTator, text mining | PubMed |
| Interplay between ALK2R206H mutant receptor and autophagy signaling regulates receptor stability and its chondrogenic functions. | Cell Death Discov | 2025 | 40121219 | PubTator, text mining | PubMed |
| Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives. | Am J Hematol | 2025 | 40062529 | PubTator, text mining | PubMed |
| Hearing loss predictive model in fibrodysplasia ossificans progressiva from a national referral center: developing an hearing loss predictive model. | JBMR Plus | 2025 | 40060915 | PubTator, text mining | PubMed |
| Emerging Pathogenetic Mechanisms and New Drugs for Anemia in Myelofibrosis and Myelodysplastic Syndromes. | Am J Hematol | 2025 | 40056069 | PubTator, text mining | PubMed |
| Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas. | J Neurooncol | 2025 | 39961939 | PubTator, text mining | PubMed |
| OpenMMDL - Simplifying the Complex: Building, Simulating, and Analyzing Protein-Ligand Systems in OpenMM. | J Chem Inf Model | 2025 | 39933881 | PubTator, text mining | PubMed |
| Helicobacter pylori infection induces DNA double-strand breaks through the ACVR1/IRF3/POLD1 signaling axis to drive gastric tumorigenesis. | Gut Microbes | 2025 | 39924917 | PubTator, text mining | PubMed |
Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. | Eur J Cancer | 2025 | 39854822 | PubTator, text mining | PubMed |
| Three-dimensional genome architecture in intrahepatic cholangiocarcinoma. | Cell Oncol (Dordr) | 2025 | 39831920 | PubTator, text mining | PubMed |
| A Recombinant Antibody Against ALK2 Promotes Tissue Iron Redistribution and Contributes to Anemia Resolution in a Mouse Model of Anemia of Inflammation. | Am J Hematol | 2025 | 39791515 | PubTator, text mining | PubMed |
| Discoidin domain receptor 2 is an important modulator of BMP signaling during heterotopic bone formation. | Bone Res | 2025 | 39746922 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=5